Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
John Huntz Insider Profile
4 Followers
John Huntz, Director at Manhattan Associates, holds 54.25K shares in Manhattan Associates (Ticker: MANH), holds 0.00 shares in Opko Health (Ticker: OPK).
Profitable Transactions
4 out of 12 Profitable Transactions
Average Return
-16.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that John Huntz holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Nov 30, 2015 - Nov 30, 2016
Return:+31.50%
The most profitable trade made by John Huntz
John Huntz's Trading History
Manhattan Associates
May 28, 2024
Director
Uninformative Buy
―
$12.21M
Opko Health
―
Director
―
$0.00
List of latest transactions for each holding click on a transaction to see John Huntz's performance on stock
You May Also Like
John Huntz insider profile FAQ
What is the percentage of profitable transactions made by John Huntz?
The percentage of profitable transactions made by John Huntz is 33%.
What is the average return per transaction made by John Huntz?
The average return per transaction made by John Huntz is -16.30%.
What stocks does John Huntz hold?
John Huntz holds: MANH, OPK stocks.
What was John Huntz’s latest transaction?
John Huntz latest transaction was an Uninformative Buy of ―.
What was John Huntz's most profitable transaction?
John Huntz’s most profitable transaction was an Informative Sell of MANH stock on November 30, 2015. The return on the trade was 31.50%.
What is John Huntz's role in Manhattan Associates?
John Huntz's role in Manhattan Associates is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.